1-14 of 14
Daniel S. Pereira
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma

Benjamin J. Capoccia, Michael J. Donio, John O. Richards, Ronald R. Hiebsch, Robyn J. Puro, Arun K. Kashyap, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 954.
https://doi.org/10.1158/1538-7445.AM2021-954
Published: 01 July 2021
View article titled, Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma
Journal Articles

Abstract 548: Evaluation of novel SIRP antibodies as potential cancer therapeutics

Ronald R. Hiebsch, Myriam N. Bouchlaka, Benjamin J. Capoccia, Michael J. Donio, Prabir Chakraborty, W. Casey Wilson, Robyn J. Puro, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 548.
https://doi.org/10.1158/1538-7445.AM2019-548
Published: 01 July 2019
View article titled, Abstract 548: Evaluation of novel SIRP antibodies as potential cancer therapeutics
Journal Articles

Abstract 540: AO-176, a normal cell sparing humanized anti-CD47 antibody

Prabir Chakraborty, Myriam N. Bouchlaka, Benjamin J. Capoccia, Ronald R. Hiebsch, Michael J. Donio, Robyn J. Puro, Vicki Sung, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 540.
https://doi.org/10.1158/1538-7445.AM2019-540
Published: 01 July 2019
View article titled, Abstract 540: AO-176, a normal cell sparing humanized anti-CD47 antibody
Journal Articles

Abstract 574: AGS62P1, a novel site-specific antibody drug conjugate targeting FLT3 exhibits potent anti-tumor activity regardless of FLT3 kinase activation status

Nandini Rudra-Ganguly, Pia M. Challita-Eid, Christine Lowe, Mike Mattie, Sung-Ju Moon, Brian A. Mendelsohn, Monica Leavitt, Cyrus Virata, Alla Verlinsky, Linnette Capo, Mi Sook Chang, Deanna L. Russell, Baljinder Randhawa, Gao Liu, René Hubert, Mary Brodey, Hector Aviña, Chunying Zhang, Joseph D. Abad, Banmeet Anand, Sher Karki, Zili An, Roland Luethy, Fernando Doñate, Daniel S. Pereira, Kendall Morrison, Ingrid B.J. Joseph, David R. Stover
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 574.
https://doi.org/10.1158/1538-7445.AM2016-574
Published: 15 July 2016
View article titled, Abstract 574: AGS62P1, a novel site-specific antibody drug conjugate targeting FLT3 exhibits potent anti-tumor activity regardless of FLT3 kinase activation status
Journal Articles

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang, Zili An, Karen Morrison, Yuriy Shostak, Arthur Raitano, Rossana Nadell, Wendy Liu, Dawn Ratay Lortie, Linnette Capo, Alla Verlinsky, Monica Leavitt, Faisal Malik, Hector Aviña, Claudia I. Guevara, Nick Dinh, Sher Karki, Banmeet S. Anand, Daniel S. Pereira, Ingrid B.J. Joseph, Fernando Doñate, Kendall Morrison, David R. Stover
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (10): 3003–3013.
https://doi.org/10.1158/0008-5472.CAN-15-1313
Published: 12 May 2016
View article titled, Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Open the PDF for Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models in another window
Includes: Supplementary data
Journal Articles

Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy

Nandini Rudra-Ganguly, Christine Lowe, Mukta Shiwalkar, Claudia I. Guevara, Christopher Kemball, Min Michelle Wu, Cyrus Virata, Alla Verlinsky, Ssucheng J Hsu, Michael Mattie, William Yeh, Peng Yang, Sung-Ju Moon, Ingrid Joseph, David R. Stover, Daniel S. Pereira, Dowdy Jacksosn
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1976.
https://doi.org/10.1158/1538-7445.AM2014-1976
Published: 01 October 2014
View article titled, Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy
Journal Articles

Abstract 2650: Ags67e, an anti-cd37 monomethyl auristatin e antibody (mmae) drug conjugate as a potential therapeutic for non-hodgkin's lymphoma, chronic lymphocytic leukemia and acute myeloid leukemia

Daniel S. Pereira, Claudia Guevara, Alla Verlinsky, Cyrus Virata, J Hsu Ssucheng, Zili An, Chungying Zhang, Nick Dinh, Hector Avina, Lisa Do, Sher Karki, Joseph Abad, Peng Yang, Jimmy Ou, Karen Morrison, Sing-Ju Moon, Faisal Malik, Liqing Jin, Michael Choi, Christina Wu, Banmeet Anand, Scott Cooper, Ingrid Joseph, Xiao-Chi Jia, Kendall Morrison, Pia Challita-Eid, Fernando Donate, Thomas Kipps, John Dick, David Stover
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2650.
https://doi.org/10.1158/1538-7445.AM2014-2650
Published: 01 October 2014
View article titled, Abstract 2650: Ags67e, an anti-cd37 monomethyl auristatin e antibody (mmae) drug conjugate as a potential therapeutic for non-hodgkin's lymphoma, chronic lymphocytic leukemia and acute myeloid leukemia
Journal Articles

Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Nandini Rudra-Ganguly, Daulet Satpayev, Christine Lowe, Liping Hu, Bally Randhawa, Mi Sook Chang, Alla Verlinsky, Jeffrey Coleman, Pia Challita-Eid, Peng Yang, Zili An, Karen Morrison, Art Raitano, Daniel S. Pereira, David Stover
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1086.
https://doi.org/10.1158/1538-7445.AM2012-1086
Published: 15 April 2012
View article titled, Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression
Journal Articles

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Jennifer M. O'Toole, Karen E. Rabenau, Kerri Burns, Dan Lu, Venkat Mangalampalli, Paul Balderes, Nicole Covino, Rajiv Bassi, Marie Prewett, Kimberly J. Gottfredsen, Megan N. Thobe, Yuan Cheng, Yiwen Li, Daniel J. Hicklin, Zhenping Zhu, Susan E. Waltz, Michael J. Hayman, Dale L. Ludwig, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2006) 66 (18): 9162–9170.
https://doi.org/10.1158/0008-5472.CAN-06-0283
Published: 18 September 2006
View article titled, Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
Open the PDF for Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member in another window
Includes: Supplementary data
Journal Articles

Therapeutic implications of a human neutralizing antibody to the Macrophage-Stimulating Protein receptor tyrosine kinase (RON) that inhibits cancer cell signaling, migration and tumorigenesis

Jennifer M. O’Toole, Karen E. Rabenau, Kerri Burns, Yuan Cheng, Dan Lu, Venkat R. M. Mangalampalli, Paul Balderes, Marie C. Prewett, Zhenping Zhu, Dale L. Ludwig, Larry Witte, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 876.
Published: 15 April 2006
View article titled, Therapeutic implications of a human neutralizing antibody to the Macrophage-Stimulating Protein receptor tyrosine kinase (RON) that inhibits cancer cell signaling, migration and tumorigenesis
Journal Articles

Therapeutic implications of an antibody to the human macrophage-stimulating protein receptor tyrosine kinase (RON)

Daniel S. Pereira, Jennifer M. O’Toole, Karen E. Rabenau, Dan Lu, Venkat Mangalampalli, Henry Koo, Anthony Kayas, Julie P. Yuen, Paul Balderes, Nicole Covino, Rajiv Bassi, Andrea Hooper, Philipp Steiner, Xenia Jimenez, Zhenping Zhu, Dale L. Ludwig, Daniel J. Hicklin, Larry Witte
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 130–131.
Published: 01 May 2005
View article titled, Therapeutic implications of an antibody to the human macrophage-stimulating protein receptor tyrosine kinase (RON)
Journal Articles

Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Dale L. Ludwig, James R. Tonra, Douglas Burtrum, Marie Prewett, Rajiv Bassi, Andrea Hooper, Daniel S. Pereira, Bridget Finnerty, Eric Corcoran, Larry Witte, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 509.
Published: 01 April 2004
View article titled, Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.
Journal Articles

DEGA/AMIGO-2, a leucine-rich repeat family member differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability and tumorigenicity

Daniel S. Pereira, Karen E. Rabenau, Jennifer M. O’Toole, Rajiv Bassi, Helen Kotanides, Dale L. Ludwig, Larry Witte
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1168.
Published: 01 April 2004
View article titled, DEGA/AMIGO-2, a leucine-rich repeat family member differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability and tumorigenicity
Journal Articles

A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S. Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T. Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J. Hicklin, Dale L. Ludwig
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8912–8921.
Published: 24 December 2003
View article titled, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em>
Open the PDF for A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em> in another window